5th Annual Lab Asset and Facility Management 2022

Pharma R and D return on investment has risen to its highest levels since 2014, there's never been a more impactful time to translate savings in capital spend into results for patients in need. The 5th LAFM Summit will return to unite lab operations, asset and facility managers in their quest to support stakeholders, manage reactive business continuity whilst providing a platform for sustainable and ambitious organizational growth.

As the only peer led community for R and D operations leaders, from large pharma to start-ups, meet your new network this November and level up your career in lab operations, facility and asset management.

New for 2022 the 5th LAFM summit will host three tracks of content to dive down into asset management and maintenance in large pharma, facility design in expanding organizations, and end-to-end operations in early-stage biotech.

Leverage next generation technologies, overcome supply chain challenges and find inspiration to make a real impact in your organization, no matter your headcount or resources.

URLs:
Website: https://go.evvnt.com/1170997-0?pid=176 
Tickets: https://go.evvnt.com/1170997-2?pid=176 
Brochure: https://go.evvnt.com/1170997-3?pid=176 

Time: 08:00 - 17:00

Prices:
Drug Developer Pricing - Conference + Workshops + 101 Bootcamp: USD 3397.00,
Drug Developer Pricing - Conference + 101 Bootcamp: USD 2998.00,
Drug Developer Pricing - Conference + Workshops: USD 2998.00,
Drug Developer Pricing - Conference Only: USD 2599.00,
Solution Provider Pricing - Conference + Workshops + 101 Bootcamp: USD 4697.00,
Solution Provider Pricing - Conference + 101 Bootcamp: USD 4148.00,
Solution Provider Pricing - Conference + Workshops: USD 4148.00,
Solution Provider Pricing - Conference Only: USD 3599.00

Speakers: Alexander Vang, Laboratory Operations Manager, Keros Therapeutics, Amanda Allen, Executive Director, Facilities and Operations, Odyssey Therapeutics, Angela Hui, Director of Operations, Elektrofi, Anna Josephson-Day, Associate Director, Lab Operations and Procurement, Neoleukin Therapeutics Inc., Bill VanDeWeghe, President and Chief Executive Officer, Copia Scientific, Charles Bruseo, Director, Research Strategy and Operations, Bristol Myers Squibb, Christiane Glanzmann, Global Expert Laboratory Workplace Strategy, Roche, Daniel Michaels, Senior Manager, Facilities and Laboratory Operations, Inozyme Pharma, David Heiger, Associate Vice President - Marketing, Agilent Technologies, Ethan Smith, General Manager, Life Sciences, Nuvolo, Jayson Bernstein, President, American Laboratory Trading Inc, JD Fier, Head of MA Bio Ops Reliability Engineering, Takeda Pharmaceutical Co. Ltd., Jena Gibson, Director of Lab Operations, Odyssey Therapeutics, Jennifer Heymont, Associate Director, Scientific Informatics, Eisai, Jessie Dow, Lab Operations Lead, Pfizer, Jill DeGreen, Senior Manager - Operations, Novo Nordisk, Jim Sweeney, Senior Product Manager, PerkinElmer, John Yi, Senior Reliability Engineer, Seagen, Justin De La Cruz, Director - DTC Technical Development, Adverum Biotechnologies, Katya Henderson, Vice President, Operations, ENSEM Therapeutics, Kevin Blewitt, Senior Laboratory and Operations Associate, Scorpion Therapeutics, Kevin Keras, Managed Services Portfolio Leader, PerkinElmer, Kim Dougherty, Director, Laboratory Operations, Atalanta Therapeutics, Luis Rodriguez, VP Sales and Marketing, RENOVO Solutions, Mark Burfoot, Global Head of Research Procurement, Novartis AG, Marloes Miller, Associate Director, R and D Lab Operations, AstraZeneca, Matthew O'Brien, Senior Director of Scientific Operations, Treeline Biosciences, Mike Berke, Director - Research and Automation Technologies, Amgen Inc., Mike Ratterman, Principal Engineer, Amgen Inc., Mikhael Danan, Director R and D, Clinical IT, Affinivax, Partha Krishnan, Deputy Director - Health, Safety and Environment, Sanofi, Polina Freitas, Senior Manager - Facilities and Operations, Apic Bio, Rachel Stilling, Director of Lab Operations, SQZ Biotech, Rasheedah Malik, Senior Manager, Assay Development, Foundation Medicine, Rhianna Cohen, Associate Director of Lab Operations, Pyxis Oncology, Richard Snell, Scientific Services Director, GSK, Robert Pemberton, Chief Commercial Officer, Elemental Machines, Sandy Morales, Director, Facilities and EH and S, Concert Pharmaceuticals, Stephen Tierney, President, XiltriX, Steven Driver, Principal Engineer and Energy Program Mananger, Sanofi, Sumita Roy, Director - Internal Operations, SOTIO, Ted Schilling, Global Director of Engineering Services, Seagen